Additionally, the 36-month beta value for PROK is 1.57. There are mixed opinions on the stock, with 4 analysts rating it as a “buy,” 0 rating it as “overweight,” 3 rating it as “hold,” and 0 rating it as “sell.”
The public float for PROK is 91.19M and currently, short sellers hold a 14.57% ratio of that float. The average trading volume of PROK on May 05, 2025 was 780.58K shares.
PROK) stock’s latest price update
The stock of ProKidney Corp (NASDAQ: PROK) has decreased by -7.59 when compared to last closing price of 0.85.Despite this, the company has seen a loss of -22.63% in its stock price over the last five trading days. zacks.com reported 2025-03-21 that PROKIDNEY CP (PROK) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
PROK’s Market Performance
PROK’s stock has fallen by -22.63% in the past week, with a monthly drop of -6.01% and a quarterly drop of -52.17%. The volatility ratio for the week is 15.62% while the volatility levels for the last 30 days are 23.85% for ProKidney Corp The simple moving average for the past 20 days is 0.49% for PROK’s stock, with a -53.01% simple moving average for the past 200 days.
Analysts’ Opinion of PROK
Guggenheim, on the other hand, stated in their research note that they expect to see PROK reach a price target of $6. The rating they have provided for PROK stocks is “Buy” according to the report published on September 10th, 2024.
Morgan Stanley gave a rating of “Equal-Weight” to PROK, setting the target price at $3 in the report published on March 07th of the previous year.
PROK Trading at -16.29% from the 50-Day Moving Average
After a stumble in the market that brought PROK to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -82.23% of loss for the given period.
Volatility was left at 23.85%, however, over the last 30 days, the volatility rate increased by 15.62%, as shares surge +10.94% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -48.08% lower at present.
During the last 5 trading sessions, PROK fell by -22.63%, which changed the moving average for the period of 200-days by -67.25% in comparison to the 20-day moving average, which settled at $0.7854. In addition, ProKidney Corp saw -53.30% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at PROK starting from Control Empresarial de Capital, who purchase 387,393 shares at the price of $0.71 back on Apr 22 ’25. After this action, Control Empresarial de Capital now owns 73,842,723 shares of ProKidney Corp, valued at $276,366 using the latest closing price.
Control Empresarial de Capital, the Add’l Rep. Persons-see Ex.99-1 of ProKidney Corp, purchase 25,000 shares at $0.75 during a trade that took place back on Apr 17 ’25, which means that Control Empresarial de Capital is holding 73,455,330 shares at $18,690 based on the most recent closing price.
Stock Fundamentals for PROK
Current profitability levels for the company are sitting at:
- -2416.79 for the present operating margin
The net margin for ProKidney Corp stands at -805.08. The total capital return value is set at -0.45.
Based on ProKidney Corp (PROK), the company’s capital structure generated -0.0 points at debt to capital in total, while cash flow to debt ratio is standing at -39.05. The debt to equity ratio resting at -0.0. The interest coverage ratio of the stock is -20408.44.
Currently, EBITDA for the company is -159.59 million with net debt to EBITDA at 0.6. When we switch over and look at the enterprise to sales, we see a ratio of 1777.8. The receivables turnover for the company is 0.03for trailing twelve months and the total asset turnover is 0.0. The liquidity ratio also appears to be rather interesting for investors as it stands at 10.93.
Conclusion
In conclusion, ProKidney Corp (PROK) has seen bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
